Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.93 USD | -2.53% | -1.03% | +4.32% |
Business Summary
Number of employees: 27
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
John Doyle
DFI | Director of Finance/CFO | 46 | 23-04-30 |
Paul J. Tiseo
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-10 |
Mary Hamby
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anthony Caggiano
CTO | Chief Tech/Sci/R&D Officer | 54 | 19-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
Brett Monia
BRD | Director/Board Member | 62 | 20-09-30 |
Ellen Richstone
BRD | Director/Board Member | 72 | 21-10-31 |
Jack Khattar
CHM | Chairman | 62 | 19-12-31 |
Peggy Wallace
BRD | Director/Board Member | 67 | 16-08-31 |
Aaron Fletcher
BRD | Director/Board Member | 44 | 14-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,039,220 | 36,054,193 ( 90.05 %) | 0 | 90.05 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.32% | 77.28M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- CGTX Stock
- Company Cognition Therapeutics, Inc.